Clinical Trial Update: Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating surufatinib in combination with immunotherapy and chemotherapy for second-line treatment of advanced colorectal cancer; current sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Surufatinib (Surufatinib)

Snippet

Sponsor: Jiangsu Cancer Institute & Hospital | Conditions: Advanced Colorectal Cancer | Phase 1, Phase 2 | Status: UNKNOWN